Connection

Samar Hammad to Lipoproteins

This is a "connection" page, showing publications Samar Hammad has written about Lipoproteins.
Connection Strength

1.569
  1. Transcriptomics Reveal Altered Metabolic and Signaling Pathways in Podocytes Exposed to C16 Ceramide-Enriched Lipoproteins. Genes (Basel). 2020 02 07; 11(2).
    View in: PubMed
    Score: 0.626
  2. Lipoprotein subclass profiles of hyperlipidemic diabetic mice measured by nuclear magnetic resonance spectroscopy. Metabolism. 2003 Jul; 52(7):916-21.
    View in: PubMed
    Score: 0.198
  3. Diabetes and kidney dysfunction markedly alter the content of sphingolipids carried by circulating lipoproteins. J Clin Lipidol. 2022 Mar-Apr; 16(2):173-183.
    View in: PubMed
    Score: 0.179
  4. Haptoglobin Phenotype Modulates Lipoprotein-Associated Risk for Preeclampsia in Women With Type 1 Diabetes. J Clin Endocrinol Metab. 2019 10 01; 104(10):4743-4755.
    View in: PubMed
    Score: 0.153
  5. Sphingolipids and Lipoproteins in Health and Metabolic Disorders. Trends Endocrinol Metab. 2017 07; 28(7):506-518.
    View in: PubMed
    Score: 0.129
  6. Accelerated vascular disease in systemic lupus erythematosus: role of macrophage. Clin Immunol. 2015 Apr; 157(2):133-44.
    View in: PubMed
    Score: 0.110
  7. Plasma lipoproteins and preeclampsia in women with type 1 diabetes: a prospective study. J Clin Endocrinol Metab. 2012 May; 97(5):1752-62.
    View in: PubMed
    Score: 0.091
  8. Blood sphingolipids in homeostasis and pathobiology. Adv Exp Med Biol. 2011; 721:57-66.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.